Elijah M. Bolotin

Pharmain Corporation

$3,712,057

Attributed

$4,844,181

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2008–14

$2M$1.5M$1M$500K$0

'08

'09

'10

'11

'12

'13

'14

Funding mix

By agency

NIH$4,844,181 · 7

By mechanism

R44$3,040,166 · 2

R43$1,804,015 · 5

Top collaborators

Gerardo M. Castillo8 shared
Sandra Reichstetter2 shared

Most similar at Pharmain Corporation

Same institution · by research overlap

Gerardo M. Castillo$15,494,100
Elijah M Bolotin$1,915,481

Others in their field

Top investigators on “Half-Life”

David Heimbrook · Leidos Biomedical Research, Inc.$44,594,272
Merit E Cudkowicz · Massachusetts General Hospital$39,269,365
Xinhua Li · Nano Terra, Inc.$30,331,442
James E Crowe · Vanderbilt University Medical Center$23,531,089
Chang-Guo Zhan · University Of Kentucky$22,890,936
Matthew W Kalnik · Antidote Therapeutics, Inc.$21,780,207

Research focus

Half-LifeIn VivoNanocarrierCopolymerPeptidesSuccessDoseSmall Business Innovation Research GrantAnimal ModelBinding (Molecular Function)In VitroPharmaceutical PreparationsDrug Delivery SystemsDrug FormulationsLicensingRattusPeptide HydrolasesDesignSiteAnimalsVascular PermeabilitiesLifeProductionKidney